Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: CD45dimCD34+CD38CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia

Fig. 4

The CD45dimCD34+CD38CD133+ cells are prominently detected in bone marrow of patients with AML and CML. As shown in Fig. 1, the CD45dimCD34+CD38CD133+ cells were examined by four-color flow cytometry in diverse hematological malignancies including AML (n = 40), CML (n = 6), DLBCL (n = 19), MM (n = 10), MDS, (n = 5), HL (n = 4), ALL (n = 3), and CLL (n = 2). Data represent mean ± SEM from three independent experiments in different AML patients. Significantly different from the control (*) or AML (#); #: P < 0.05.; ***, ###: P < 0.001. HC, healthy controls; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; DLBCL, diffuse large B-cell lymphoma; MM, multiple myeloma; MDS, myelodysplastic syndrome; HL, Hodgkin lymphoma; ALL, acute lymphocytic leukemia; CLL, chronic lymphocytic leukemia

Back to article page